A Florida-based endocrinologist, Victor L. Roberts, MD, has led a private practice in Lake Mary for nearly three decades. Over the course of his career, he has received a number of accolades for his work. For instance, Victor L. Roberts, MD, has been listed in the Marquis Who’s Who in America multiple times. He has also earned the Castle Connolly Top Doctors award. In its mission to connect consumers with the best health care available, Castle Connolly Medical Ltd. publishes an annual list of the nation’s best physicians. The list, America’s Top Doctors, has been featured on television and in a number of publications, including the New York Times, the Boston Herald, Fortune, and Money Magazine. Castle Connolly’s selection process begins with the creation of a candidate pool based on peer nominations from thousands of doctors across the country. The Castle Connolly physician-led research team then screens each nominee to evaluate their education and training as well as their professional credentials and achievements. The nominees’ disciplinary histories are also taken into consideration. Each year, Castle Connolly contacts more than 50,000 physicians and other health care professionals in order to narrow a pool of nearly 100,000 nominees down to its final list of America’s Top Doctors. The organization then publishes the list in its books and on its website.
0 Comments
Since 1988, endocrinologist Victor L. Roberts, MD, has served as president and chief executive officer at Endocrine Associates of Florida in Lake Mary. Alongside his day-to-day professional activities, Victor L. Roberts, MD, maintains affiliations with a number of organizations, including the American College of Physicians and the American Diabetes Association. In an April 2018 press release, the American Diabetes Association (ADA) announced the launch of a new program to reduce the incidence of type 2 diabetes in Americans over the age of 60. Currently, more than 25 percent of seniors aged 65 and up are living with type 2 diabetes, and nearly half of all seniors in Medicare have prediabetes. In addition to posing a serious health threat to the nation’s senior citizens, diabetes also costs the country an estimated $327 billion each year. The ADA’s Medicare Diabetes Prevention Program (MDPP) will provide evidence-based community interventions through group learning sessions, to help seniors with prediabetes improve their diet, increase physical activity, and manage their weight. The program will include 16 core sessions taught over a six-month period and using a curriculum approved by the Centers for Disease Control and Prevention. MDPP will also include monthly follow-up meetings to help participants maintain healthy behaviors. The ADA estimates that the program could save up to $2,650 in health care costs for each enrollee. For more information, visit www.diabetes.org. Victor L. Roberts, MD, has led as founding president and CEO of Endocrine Associates of Florida for 30 years. Also a member of the American College of Endocrinology and the American Diabetes Association, Victor L. Roberts, MD, comes to his work with a detailed and current knowledge of the conditions he treats. Although scientists have long since established excess weight as a risk factor for diabetes, little research has been done to determine if any particular types of fat deposits are more dangerous than others. Now, however, a study out of the United Kingdom and United States has suggested that a particular variant of the fat storage gene KLF14 may impact fat storage as well as level of diabetes risk. The team found a variation of the KLF14 gene that predisposed women to store excess fat around the hips rather than in the abdominal region. Not only were fat cells smaller in women with this variant, but the risk of diabetes was significantly lower. The other variant of the gene, which prompts fat storage in the abdomen, leads to much larger and fuller fat cells. Many of these cells demonstrate insufficiency of fat storage and are thus more likely to place the patient at risk for diabetes. The research team found that this trend applied only to female patients, and only to those who inherited the more risky gene variant from the maternal line. For these women, diabetes risk increased approximately 30 percent over the average. Researchers believe that these findings may be effective in understanding disease development, while potentially contributing to new treatments as personalized medicine advances. 5/29/2018 0 Comments Types of Gaucher DiseaseA highly respected endocrinologist, Victor L. Roberts, MD, has earned listing in Who's Who in Medicine and Healthcare as well as Who's Who in America. Victor L. Roberts, MD, applies his expertise as president, CEO, and physician at Endocrine Associates of Florida, where he treats a variety of metabolic disorders. Metabolic disorders may come in a variety of forms, one of which is the lysomal storage disorder. These affect structures known as lysosomes, a cell body responsible for the breakdown of metabolic waste products. If these structures do not function properly, toxins can build up and cause damage in various body systems. In cases of Gaucher disease, for example, the body lacks the enzyme it needs to properly break down a certain type of fat. This fat then builds up in the bone marrow, liver, and spleen. In the Western world, most cases of Gaucher disease can be classified as type 1, which may be asymptomatic but may also result in bone, blood, and organ abnormalities. Common symptoms include spleen and liver enlargement, low blood counts, and bone pain. The disease is treatable and involves no neurological abnormalities. Type 2 Gaucher disease, also known as acute infantile neuronopathic Gaucher disease, does involve serious neurological symptoms. As its name indicates, it typically develops in babies and toddlers, who usually do not live past the age of 2. Infants with the condition present with slow horizontal eye movement, seizures, and an overall failure to thrive. Type 3 Gaucher disease also affects the nervous system and causes similar symptoms, but it develops later in childhood. It may also have a better prognosis as compared to the type 2 form, depending on symptom set. Non-neurological symptoms of type 3 may be treatable, although no medicine can yet address the neurological symptoms of types 2 and 3 of the disease, as the blood-brain barrier blocks enzyme replacement medications. Victor L. Roberts, MD, serves patients in the Lake Mary, Florida, community with health issues such as diabetes and metabolic imbalances. Victor L. Roberts, MD, is particularly knowledgeable about the endocrine system, which encompasses the glands that regulate, among other things, growth, mood, sexual function, and sleep. One disorder of the endocrine system affecting approximately 10 million people nationwide, hypothyroidism refers to a condition in which the thyroid gland fails to produce sufficient quantities of thyroid hormone to satisfy the body’s requirements. In addition to a slower-than-average metabolism, symptoms associated with the disease can include depression, diminished libido, fatigue, and weakness. Hypothyroidism is often caused by thyroid gland inflammation, which is most commonly associated with the immune system and autoimmune thyroiditis. It can also result from medical treatments such as thyroid cancer surgery and radioactive iodine therapy, which may leave insufficient thyroid producing cells in place. Typically pharmaceutical in nature, hypothyroidism treatments include levothyroxine. 8/9/2017 0 Comments AACE's Self-Assessment ProgramAn alumnus of Upstate Medical University in Syracuse, New York, Victor L. Roberts, MD, is a Florida-based medical practitioner with over three decades of experience in the field of endocrinology. He is currently the president and chief executive officer of Endocrine Associates of Florida, P.A. Actively engaged in his area of specialization, Victor L. Roberts, MD, is an editor of First Messenger, a bimonthly publication of the American Association of Clinical Endocrinologists. Founded in 1991, AACE is a professional organization dedicated to the promotion of clinical endocrinology with the goal of achieving a better state of public health and patient care. The organization helps endocrinology practitioners uphold the highest levels of practice standards by providing several options for continuing education, one of which is a self-assessment program. AACE's self-assessment program features a core curriculum that gives updated information on the assessment, diagnosis, treatment, and other aspects of managing endocrine-system conditions. Course materials are specially designed to satisfy the cognitive needs of practitioners, thereby ensuring greater efficacy in the delivery of care. The program is purely online, and to ensure that attendees have completely understood the concepts presented, they need to pass a post-activity evaluation prior to receiving credit. Access to the 76 available credits costs $375. Those interested in learning more about the program may visit education.aace.com. A well-established Lake Mary physician, Victor L. Roberts, MD, functions as the president and CEO of Endocrine Associates of Florida, PA. Committed to providing quality care, Victor L. Roberts, MD, treats patients with diabetes, endocrine conditions, and metabolic disorders. With metabolism defining the rate at which we burn calories, basal metabolic rate (BMR) is used to measure those consumed while the body is at rest. This is defined by factors such as gender, body composition, and genetics. BMR decreases over the lifespan, as hormonal changes occur and the body’s fat storage and weight loss capacities also change. For women, this occurs around the time of menopause, with an estrogen decrease having a major effect in slowing down metabolism. In addition, the pituitary gland stops producing as much growth hormone as aging occurs. Growth hormone’s functions include helping increase protein production and build muscle mass, as well as utilize fat as efficiently as possible. When growth hormone levels trail off, the body is no longer able to break down calories as well and weight issues can ensue. A fellow of the American College of Endocrinology and the American College of Physicians, Victor Roberts, MD, established his practice in 1988 in Florida. Alongside his career, Victor Roberts, MD, also serves as a volunteer with the Central Florida Medical Reserve Corps (MRC). Composed of administrative and healthcare professionals, the Central Florida MRC provides support for emergency medical workers of various disaster response agencies. Members of the MRC undergo training to prepare them to assist in emergency situations. Anyone living or working within the counties of Brevard, Orange, and Osceola may volunteer for the Central Florida MRC unit, regardless of medical experience. Although the unit needs trained professionals and disease specialists, it also receives support from non-medical volunteers such as amateur radio operators, chaplains, and interpreters. Benefits of volunteering with the MRC range from the opportunity to receive free disaster response training to networking with peers. Serving your local community can also provide you with a sense of pride and satisfaction in being able to give back. The founder of Endocrine Associates of Florida, PA, Victor Roberts, MD, draws on over three decades of experience in providing personalized endocrine, diabetic, and metabolic patient care. Professionally, Victor Roberts, MD, maintains membership in organizations such as the American College of Endocrinology (ACE). Dedicated to enhancing patient care in the field of endocrinology, ACE serves as a charitable and scientific organization. In addition to serving as a leader in clinical research and public education, ACE also offers members the opportunity to participate in clinical symposia and other accreditation courses. Upcoming courses for 2017 include the AACE/ACE Advanced Neck Ultrasound Training Course (TM) from September 9-10 at DFW Marriott South in Fort Worth, Texas. From November 4-5, the AACE/ACE Principles of Endocrine Neck Sonography Course (TM) will take place at Westin Atlanta Airport in Atlanta, Georgia. Both of these courses qualify for credit for AMA PRA. Call 800-228-9290 to reserve your spot or visit www.aace.com to learn about other upcoming events and educational opportunities. 7/10/2012 0 Comments Victor L. Roberts, M.D., Professor of Internal Medicine at the University of Central Florida College of Medicine, Discusses the Increase in the Incidence and Prevalence of Diabetes MellitusBased in Florida, Dr. Victor Lawrence Roberts has served as an endocrinologist for more than 27 years. A member of the American Diabetes Association, the American Association of Clinical Endocrinologists, and the Endocrine Society, Dr. Roberts treats patients with diabetes, metabolic disorders, lipid abnormalities, osteoporosis, thyroid conditions, and pituitary dysfunction.
Diabetes affects an increasing number of Americans every year. In the United States, almost 26 million individuals have the disease in 2011, according to the U.S. Centers for Disease Control and Prevention (CDC). Worldwide, this number is an astounding 390,000,000 people. The CDC attributes this increase to several factors: 1. A new test facilitates diagnoses. Medical professionals have just begun utilizing hemoglobin A1c as a marker. The gauge measures blood glucose levels across several months. 2. An increase in patients with the disease (increased incidence and prevalence), corresponding to the epidemic of obesity. 3. Longer lifespans for people with diabetes. With improved care, individuals with diabetes now can manage their disease and live longer. Related complications, such as neuropathy, retinopathy, and nephropathy, are all potentially preventable and certainly treatable. In Florida, physicians have diagnosed nearly 10 percent of the adult population with the condition. Of those, nearly half have not learned how to manage the disease. There is a disproportionate number of patients diagnosed with diabetes (usually DM2) in the African-American, Hispanic-American, Native-American, and Asian-American populations. Although DM2 affects the majority of the diabetic population, DM1, formerly referred to as juvenile diabetes or insulin-dependent diabetes, continues to be a major health care challenge. Currently, a child born in 2012 has a 1 in 3 chance of becoming diabetic by 2050. Vigilance in identifying people at risk for diabetes must be part of our health care delivery system, with the hope of prevention and optimal care for those suffering from the disease. |
AuthorDr. Victor Roberts Archives
September 2021
CategoriesAll Community Outreach Covid-19 Cushing’s Syndrome Diabetes Health Hormonal Causes Hypothyroidism Urination Victor L Roberts MD |